Be part of the knowledge.™

Neurology and Neurosurgery

2550

LikeLikedUnlike

1-15 of 768

Detecting Schizophrenia Early: Clinical Challenges and Future Directions
NeuroFrontiers
Detecting Schizophrenia Early: Clinical Challenges and Future Directions
- Jeffrey Lieberman, MD
  Peer
Overcoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
NeuroFrontiers
Overcoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Tushita Mayanil, MBBS, MD
  Peer
- Melanie Yabs, PharmD, MS, BCPP
  Peer
Supporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
NeuroFrontiers
Supporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Hannah Brown, MD
  Peer
Beyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
NeuroFrontiers
Beyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
- Ashley Baker, MSN, PMHNP
  Peer
- Stephen Marder, MD
  Peer
Identifying and Managing Violence Risk in Schizophrenia Care
On the Frontlines of Schizophrenia
Identifying and Managing Violence Risk in Schizophrenia Care
- Alexandria May, PharmD, BCPS
  Peer
- Ragy R. Girgis, MD, MS
  Peer
Digital Danger: Understanding AI Psychosis in Schizophrenia
On the Frontlines of Schizophrenia
Digital Danger: Understanding AI Psychosis in Schizophrenia
- Alexandria May, PharmD, BCPS
  Peer
- Ragy R. Girgis, MD, MS
  Peer
advertisement
Cracking the Migraine Code: How AI May Transform Diagnosis and Treatment
On the Frontlines of Migraine
Cracking the Migraine Code: How AI May Transform Diagnosis and Treatment
- Ashley Baker, MSN, PMHNP
  Peer
- Chia-Chun Chiang, MD
  Peer
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Project Oncology®
Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
- Alexandria May, PharmD, BCPS
  Peer
- Nicholas Whipple, MD, MPH
  Peer
Rethinking Schizophrenia Guidelines: Why It’s Time to Incorporate Novel Mechanisms
NeuroFrontiers
Rethinking Schizophrenia Guidelines: Why It’s Time to Incorporate Novel Mechanisms
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Desiree Matthews, PMHNP-BC
  Peer
Growth Recovery After Tovorafenib in Pediatric Low-Grade Gliomas: New Data
Project Oncology®
Growth Recovery After Tovorafenib in Pediatric Low-Grade Gliomas: New Data
- Alexandria May, PharmD, BCPS
  Peer
- Daniel Landi, MD
  Peer
Bridging Inpatient to Outpatient Schizophrenia Care: Solutions for Safer Transitions
NeuroFrontiers
Bridging Inpatient to Outpatient Schizophrenia Care: Solutions for Safer Transitions
- Shelina Ramnarine, PhD
  Peer
- Michelle Scargle, MD
  Peer
- Margaret Emerson, DNP, APRN, PMHNP-BC
  Peer
Negative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
On the Frontlines of Schizophrenia
Negative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
- Brian P. McDonough, MD, FAAFP
  Peer
- Ahmed Makhlouf, MD
  Peer
advertisement
Advancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients
NeuroFrontiers
Advancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Ragy R. Girgis, MD, MS
  Peer
- Desiree Matthews, PMHNP-BC
  Peer
Using fMRI to Identify Early Alzheimer’s Disease Subgroups
NeuroFrontiers
Using fMRI to Identify Early Alzheimer’s Disease Subgroups
- Hamid Abuwarda, PhD, BS
  Peer
Evaluating AR1001: A Phase 3 Trial in Early Alzheimer’s Disease
NeuroFrontiers
Evaluating AR1001: A Phase 3 Trial in Early Alzheimer’s Disease
- Sharon Sha, MD, MS
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended